LA
LVACW

Linden Advisors’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Linden Advisors’s Portfolio LVACW Stock Details LVACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-124,999
Closed -$10.6K – 474
2023
Q1 		$10.6K Hold
124,999
– – ﹤0.01% 425
2022
Q4 		$1.1K Hold
124,999
– – ﹤0.01% 570
2022
Q3 		$16K Hold
124,999
– – ﹤0.01% 609
2022
Q2 		$12K Hold
124,999
– – ﹤0.01% 693
2022
Q1 		$40K Buy
+124,999
New +$50.6K ﹤0.01% 680

Linden Advisors's LVACW Position: Q2 2023 in Review

Linden Advisors sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 124,999 shares — an estimated $10.6K sold.

Linden Advisors first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $40K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

  • Linden Advisors reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
  • Linden Advisors sold 124,999 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $10.6K.
  • Linden Advisors first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
  • Linden Advisors's LAVA Medtech Acquisition Corp. Warrants position peaked at $40K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Linden Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.